Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Nicol Macpherson, Richard J. Klasa, Randy Gascoyne, Susan E. O'Reilly, Nicholas Voss & Joseph M. Connors. (2002) Treatment of Elderly Hodgkin's Lymphoma Patients with a Novel 5-drug Regimen (ODBEP): A Phase II Study. Leukemia & Lymphoma 43:7, pages 1395-1402.
Read now
Read now
Rose-Marie Amini, Gunilla Enblad, Peter Engström, Birger Christensson, Bengt Glimelius & Christer Sundström. (2002) Relapsed Hodgkin's Lymphoma: Immunostaining Patterns in Relation to Survival. Leukemia & Lymphoma 43:6, pages 1253-1260.
Read now
Read now
Daniel Molin, Bengt Glimelius, Christer Sundström, Per Venge & Gunilla Enblad. (2001) The Serum Levels of Eosinophil Cationic Protein (ECP) Are Related to the Infiltration of Eosinophils in the Tumours of Patients with Hodgkin's Disease. Leukemia & Lymphoma 42:3, pages 457-465.
Read now
Read now
Gunilla Enblad, Kristian Sandvej, Christer Sundstrom, Gorm Pallesen & Bengt Glimelius. (1999) Epstein-Barr Virus Distribution in Hodgkin's Disease in an Unselected Swedish Population. Acta Oncologica 38:4, pages 425-429.
Read now
Read now
Anita Gustavsson. (1997) Editorial: The Long-Term Consequences of Therapy for Hodgkin's Disease Are Still Evolving. Acta Oncologica 36:1, pages 1-2.
Read now
Read now
Anita Gustavsson. (1997) G-CSF (Filgrastim) as an Adjunct to MOPP/ABVD Therapy in Hodgkin's Disease. Acta Oncologica 36:5, pages 483-488.
Read now
Read now
Gunilla Enblad, Rose-Marie Amini, Christer Sundström & Bengt Glimelius. (1997) Serum Levels of Soluble CD 30 and Their Relationship to Tumour Burden and Prognosis in Patients with Hodgkin's Disease. Hematology 2:2, pages 113-123.
Read now
Read now
Articles from other publishers (21)
Caroline E. Weibull, Magnus Björkholm, Ingrid Glimelius, Paul C. Lambert, Therese M. L. Andersson, Karin E. Smedby, Paul W. Dickman & Sandra Eloranta. (2019) Temporal trends in treatment‐related incidence of diseases of the circulatory system among Hodgkin lymphoma patients. International Journal of Cancer 145:5, pages 1200-1208.
Crossref
Crossref
Caroline E. WeibullAnna L.V. JohanssonSandra ElorantaKarin E. SmedbyMagnus BjörkholmPaul C. LambertPaul W. DickmanIngrid Glimelius. (2018) Contemporarily Treated Patients With Hodgkin Lymphoma Have Childbearing Potential in Line With Matched Comparators. Journal of Clinical Oncology 36:26, pages 2718-2725.
Crossref
Crossref
Magnus Björkholm, Caroline E. Weibull, Sandra Eloranta, Karin E. Smedby, Ingrid Glimelius & Paul W. Dickman. (2018) Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma-A population-based study from Sweden. European Journal of Haematology 101:1, pages 106-114.
Crossref
Crossref
Sandra ElorantaPaul C. LambertJan SjöbergTherese M.L. AnderssonMagnus BjörkholmPaul W. Dickman. (2013) Temporal Trends in Mortality From Diseases of the Circulatory System After Treatment for Hodgkin Lymphoma: A Population-Based Cohort Study in Sweden (1973 to 2006). Journal of Clinical Oncology 31:11, pages 1435-1441.
Crossref
Crossref
Jan SjöbergCat Halthur, Sigurdur Y. KristinssonOla Landgren, Ulla Axdorph NygellPaul W. Dickman & Magnus Björkholm. (2012) Progress in Hodgkin lymphoma: a population-based study on patients diagnosed in Sweden from 1973-2009. Blood 119:4, pages 990-996.
Crossref
Crossref
Zsófia Miltényi, Zsófia Simon, Edit Páyer, László Váróczy, Lajos Gergely, Ádám Jóna & Árpád Illés. (2011) Changing Patterns in the Clinical Pathological Features of Hodgkin Lymphoma: A Report from Debrecen, Hungary. ISRN Hematology 2011, pages 1-7.
Crossref
Crossref
Zsófia Miltényi, Zsófia Simon, Edit Páyer, László Váróczy, Lajos Gergely, Ádám Jóna & Árpád Illés. (2010) Changing patterns in the clinic pathological features of Hodgkin lymphoma. Orvosi Hetilap 151:49, pages 2011-2018.
Crossref
Crossref
Honar Cherif, Ola Landgren, Helle B Konradsen, Mats Kalin & Magnus Björkholm. (2006) Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine 24:1, pages 75-81.
Crossref
Crossref
Carolyn Featherstone, Geoff Delaney, Susannah Jacob & Michael Barton. (2005) Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence. Cancer 103:2, pages 383-392.
Crossref
Crossref
O. Landgren, M. Bjorkholm, H. B. Konradsen, M. Soderqvist, B. Nilsson, A. Gustavsson, U. Axdorph, M. Kalin & G. Grimfors. (2004) A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma. Journal of Internal Medicine 255:6, pages 664-673.
Crossref
Crossref
Ingrid Glimelius, Daniel Molin, Rose-Marie Amini, Anita Gustavsson, Bengt Glimelius & Gunilla Enblad. (2003) Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB. European Journal of Haematology 71:5, pages 327-333.
Crossref
Crossref
Daniel Molin, Gunilla Enblad, Anita Gustavsson, Tor Ekman, Martin Erlanson, Eva Haapaniemi & Bengt Glimelius. (2003) Early and intermediate stage Hodgkin's lymphoma - report from the Swedish National Care Programme. European Journal of Haematology 70:3, pages 172-180.
Crossref
Crossref
Daniel Molin, Annika Edström, Ingrid Glimelius, Bengt Glimelius, Gunnar Nilsson, Christer Sundström & Gunilla Enblad. (2002) Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. British Journal of Haematology 119:1, pages 122-124.
Crossref
Crossref
Greta Corrales, Rosa Somoza Núñez, Jean Desenne Labonardier, Aixa Müller, María Alejandra Torres, Elsa Tovar, Nelson Urdaneta Laffe, Alicia Páez, Mercedes León, Carlos de García, Esther Arbona & Oswaldo Travieso Travieso. (2002) Tratamiento de la enfermedad de Hodgkin, esquema MOPP/ABVHodgkin’s disease: long term results (10y) of hybrid chemotherapy (MOPP/ABV) with emphasis on secondary cancer. Revista de Oncología 4:7, pages 378-384.
Crossref
Crossref
Rose‐Marie Amini, Bengt Glimelius, Anita Gustavsson, Tor Ekman, Martin Erlanson, Eva Haapaniemi & Gunilla Enblad. (2002) A population‐based study of the outcome for patients with first relapse of Hodgkin's lymphoma. European Journal of Haematology 68:4, pages 225-232.
Crossref
Crossref
Daniel Molin, Marie Fischer, Zou Xiang, Ulrika Larsson, Ilkka Harvima, Per Venge, Kenneth Nilsson, Christer Sundström, Gunilla Enblad & Gunnar Nilsson. (2001) Mast cells express functional CD30 ligand and are the predominant CD30L‐positive cells in Hodgkin's disease. British Journal of Haematology 114:3, pages 616-623.
Crossref
Crossref
Silvia Montoto, Mireia Cam�s, Armando L�pez-Guillermo, Francesc Bosch, Francisco Cervantes, Joan Blad�, Jordi Esteve, Francesc Cobo, Benet Nomdedeu, El�as Campo & Emilio Montserrat. (2000) Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced hodgkin disease. Cancer 88:9, pages 2142-2148.
Crossref
Crossref
Dirk Hasenclever, Volker Diehl, James O. Armitage, David Assouline, Magnus Björkholm, Ercole Brusamolino, George P. Canellos, Patrice Carde, Derek Crowther, David Cunningham, Houchingue Eghbali, Christophe Ferm, Richard I. Fisher, John H. Glick, Bengt Glimelius, Paolo G. Gobbi, Harald Holte, Sandra J. Horning, T. Andrew Lister, Dan L. Longo, Franco Mandelli, Aaron Polliack, Stephen J. Proctor, Lena Specht, John W. Sweetenham & Gillian Vaughan Hudson. (1998) A Prognostic Score for Advanced Hodgkin's Disease. New England Journal of Medicine 339:21, pages 1506-1514.
Crossref
Crossref
Gunilla Enblad, Hans Hagberg, Anita Gustavsson & Bengt Glimelius. (2009) Methyl‐GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective study. European Journal of Haematology 60:3, pages 166-171.
Crossref
Crossref
Gunilla Enblad, Kristian Sandvej, Evelyne Lennette, Christer Sundström, Georg Klein, Bengt Glimelius & Gorm Pallesen. (1997) Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. International Journal of Cancer 72:3, pages 394-397.
Crossref
Crossref
Rose-Marie Amini, Gunilla Enblad, Christer Sundström & Bengt Glimelius. (1997) Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: A clinico-pathological and immuno-histochemical population-based study of 32 patients. International Journal of Cancer 71:4, pages 510-516.
Crossref
Crossref